image
Healthcare - Biotechnology - NASDAQ - US
$ 49.58
-7.45 %
$ 5.52 B
Market Cap
-53.89
P/E
INCOME STATEMENT
0 REVENUE
0.00%
-101 M OPERATING INCOME
-43.31%
-85.9 M NET INCOME
-24.73%
EFFICIENCY
Earnings Waterfall Viking Therapeutics, Inc.
image
Revenue 0
Cost Of Revenue 292 K
Gross Profit -292 K
Operating Expenses 101 M
Operating Income -101 M
Other Expenses -14.9 M
Net Income -85.9 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012
REVENUE
Revenue 0 0 0 0 0 0 0 0 0 0 0 0
GROSS PROFIT
Cost Of Revenue 0.3 0.3 0.3 0.3 0.3 0 0 0 0 0 0 0
Gross Profit (0.3) (0.3) (0.3) (0.3) (0.3) 0 0 0 0 0 0 0
OPERATING INCOME
Operating Expenses 100.8 70.4 55.7 42.7 32.7 26.2 19.1 13.8 12.0 23.5 0.1 439
Selling, General and Administrative Expenses 37.0 16.1 10.7 10.7 9.1 7.1 5.3 4.8 5.0 1.2 89.5 K 163
Research and Development Expenses 63.8 54.2 45.0 31.9 23.6 19.0 13.7 9.0 7.0 22.2 11.6 K 275
Operating Income (100.8) (70.4) (55.7) (42.7) (32.7) (26.2) (19.1) (13.8) (12.0) (23.5) (0.1) 439
PRE-TAX INCOME
Interest Income Expense 88 K (1.5) 18 K 0.1 0.1 0.4 1.3 1.8 1.0 0.6 24.5 K 0
Total Other Income 14.9 1.5 0.7 3.2 6.9 4.1 (1.5) (0.9) (11.4) 1.6 45.2 K (0.1)
Pre-Tax Income (85.9) (68.9) (55.0) (39.5) (25.8) (22.1) (20.6) (14.7) (23.4) (21.9) (0.1) 444
NET INCOME
Tax Provision 0 (1.5) (1.0) (3.4) 7.0 (2.7) 1.9 1.9 1.0 0.6 24.5 K 5.54
Net Income (85.9) (67.4) (54.0) (36.1) (25.8) (22.1) (20.6) (14.7) (23.4) (21.9) (0.1) 444
EPS 0.91 0.88 0.7 0.5 0.36 0.38 0.79 0.9 3.68 5.08 0.0339 0.3